HLS Therapeutics Inc. (TSX:HLS)
Canada
· Delayed Price · Currency is CAD 4.360
-0.040 (-0.91%)
At close: Mar 6, 2026
HLS Therapeutics Ratios and Metrics
Market cap in millions CAD. Fiscal year is January - December.
Millions CAD. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 5, 2026 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 - 2015 |
| Market Capitalization | 136 | 125 | 127 | 318 | 487 | 571 | Upgrade
|
| Market Cap Growth | 2.36% | -1.37% | -60.20% | -34.60% | -14.81% | -27.86% | Upgrade
|
| Enterprise Value | 197 | 194 | 220 | 426 | 586 | 692 | Upgrade
|
| Last Close Price | 4.36 | 3.93 | 3.95 | 9.69 | 14.56 | 17.28 | Upgrade
|
| Forward PE | - | - | - | - | - | 20.62 | Upgrade
|
| PS Ratio | 1.75 | 1.53 | 1.52 | 3.83 | 6.41 | 7.99 | Upgrade
|
| PB Ratio | 1.59 | 1.22 | 0.98 | 1.88 | 2.39 | 2.65 | Upgrade
|
| P/FCF Ratio | 7.18 | 10.87 | 6.09 | 13.92 | 23.48 | 48.18 | Upgrade
|
| P/OCF Ratio | 7.08 | 10.85 | 6.08 | 13.88 | 23.41 | 47.99 | Upgrade
|
| EV/Sales Ratio | 2.53 | 2.38 | 2.64 | 5.12 | 7.71 | 9.67 | Upgrade
|
| EV/EBITDA Ratio | 8.24 | 8.99 | 7.74 | 15.14 | 19.78 | 26.32 | Upgrade
|
| EV/FCF Ratio | 10.35 | 16.88 | 10.57 | 18.63 | 28.26 | 58.31 | Upgrade
|
| Debt / Equity Ratio | 0.88 | 0.93 | 0.90 | 0.78 | 0.61 | 0.65 | Upgrade
|
| Debt / EBITDA Ratio | 3.15 | 4.42 | 4.06 | 4.66 | 4.07 | 5.17 | Upgrade
|
| Debt / FCF Ratio | 3.97 | 8.32 | 5.56 | 5.76 | 5.96 | 11.73 | Upgrade
|
| Net Debt / Equity Ratio | 0.70 | 0.69 | 0.67 | 0.61 | 0.48 | 0.52 | Upgrade
|
| Net Debt / EBITDA Ratio | 2.53 | 3.27 | 3.05 | 3.68 | 3.26 | 4.29 | Upgrade
|
| Net Debt / FCF Ratio | 3.18 | 6.13 | 4.17 | 4.54 | 4.66 | 9.51 | Upgrade
|
| Asset Turnover | 0.36 | 0.31 | 0.28 | 0.24 | 0.21 | 0.18 | Upgrade
|
| Inventory Turnover | 2.13 | 1.58 | 1.43 | 1.20 | 0.99 | 1.43 | Upgrade
|
| Quick Ratio | 0.81 | 1.11 | 1.22 | 1.02 | 1.18 | 0.93 | Upgrade
|
| Current Ratio | 1.17 | 1.57 | 1.65 | 1.42 | 1.58 | 1.29 | Upgrade
|
| Return on Equity (ROE) | -20.02% | -23.25% | -24.69% | -16.50% | -7.95% | -8.82% | Upgrade
|
| Return on Assets (ROA) | -1.86% | -2.60% | -2.87% | -3.26% | -1.35% | -2.42% | Upgrade
|
| Return on Capital Employed (ROCE) | -4.00% | -5.60% | -5.70% | -6.40% | -2.50% | -4.50% | Upgrade
|
| Earnings Yield | -14.42% | -22.63% | -28.70% | -10.03% | -3.41% | -3.42% | Upgrade
|
| FCF Yield | 13.94% | 9.20% | 16.42% | 7.18% | 4.26% | 2.08% | Upgrade
|
| Dividend Yield | - | - | 2.53% | 2.06% | 1.37% | 1.16% | Upgrade
|
| Buyback Yield / Dilution | 0.81% | 1.31% | 0.52% | -0.77% | -1.48% | -8.01% | Upgrade
|
| Total Shareholder Return | 0.81% | 1.31% | 3.06% | 1.29% | -0.11% | -6.86% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.